Lead Sponsor
Executive Sponsors
Associate Sponsors
Showcase Sponsors
Supporting Sponsors
Supporting/Educational Partner
2021 Media Partner
2021 Speaking Faculty
Stewart Abbot, PhD
Chief Scientific and Operating Officer
Adicet Bio
Rafael Amado, MD
EVP, Research and Development & CMO
Allogene Therapeutics
Arie Belldegrun, MD
Executive Chairman & Co-founder
Allogene Therapeutics
Jennifer Brogdon, PhD
Executive Director, Head of Cell Therapy Research, Exploratory Immuno-Oncology
Novartis Institutes for BioMedical Research (NIBR)
Lisa Butterfield, PhD
VP, Research and Development
Parker Institute for Cancer Immunotherapy
David Chang, MD, PhD
President, Chief Executive Officer & Co-Founder
Allogene Therapeutics
Tom Davis, MD
Chief Medical Officer
Genocea
Ken Drazan, MD
Co-founder & CEO
ArsenalBio
Jakob Dupont, MD
EVP, Head of Global Research & Development,
Atara Bio
Maria Fardis, PhD
President and CEO
IOVANCE Biotherapeutics
Niki Gallo
Associate Principal Consultant, Regulatory Affairs
Halloran Consulting Group
Rachel Gaskell
Senior Director, Clinical Development
GSK
Asthika Goonewardene, MBA
Managing Director, Senior Biotech Analyst
Truist Securities
Fred Hassan, MBA
Director, Healthcare and Consumer
Warburg Pincus
Kristen Hege, MD
SVP, Early Clinical Development, Hematology/Oncology & Cell Therapy
BMS
Ramy Ibrahim, MD
Chief Medical Officer and VP, Clinical Development
Parker Institute for Cancer Immunotherapy
Julie K Jadlowsky, PhD
Director of Translational Science, Center for Cellular Immunotherapies, Perelman School of Medicine
University of Pennsylvania
Michael Kalos, PhD
Independent Consultant
Next Pillar Consulting
Tamara Laskowski, PhD
Scientific Project Director – CAR NK Program, Adoptive Cell Therapy Platform, Dept. of Stem Cell Transplantation and Cellular Therapy
MD Anderson Cancer Center
Peter Marks, MD, PhD
Director
Center for Biologics Evaluation and Research (CBER), FDA
Hy Levitsky, MD
President, R&D
Century Therapeutics
Thomas Manley, MD
VP, Clinical Development and Medical Affairs
Adaptive Biotechnologies
Shree Patel, PhD
SVP, Clinical Operations
Achilles Therapeutics
Deborah Phippard, PhD
Global Head, Research
Precision for Medicine
Chris Ramsborg, PhD
Vice President, Cell and Gene Therapy Process Science & Technology
BMS
Vijay Reddy, MD
Chief Research and Development Officer
Tmunity
Kole Roybal, PhD
Assistant Professor, Microbiology & Immunology
University of California, San Francisco
Hardeep Samra, PhD
Principal Consultant, Regulatory
Halloran Consulting Group
Dolores Schendel, PhD
CEO & CSO
Medigene AG
Aiman Shalabi, PharmD
VP R&D, Cell and Gene Therapies
GSK
Gary Shapiro, PhD
Director, Immuno-Oncology Research
Takeda Pharmaceuticals
Mark Stewart, PhD
VP, Science Policy
Friends of Cancer Research
Helen Tayton-Martin, PhD
Chief Business Officer
Adaptimmune
Pascal Touchon
President & CEO
Atara Biotherapeutics
James Trager, PhD
Chief Scientific Officer
Nkarta Therapeutics
Scott Welden
Senior Project Manager, Novel and Emerging Therapies, Oncology and Hematology Business Unit
Syneos Health